Physician profile
Scott A Slavis
NPI 1700879053
$879.39
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $180 · 2021: $41.80.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $248.10 | 2019-2021 | |
| Neotract INC. | $141.52 | 2020 | |
| Abbvie INC. | $121.56 | 2019 | |
| Olympus America INC. | $116.96 | 2019 | |
| Agiliti Surgical, INC. | $60.46 | 2019 | |
| Dendreon Pharmaceuticals LLC | $22.97 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $21.59 | 2019 | |
| Spectrum Pharmaceuticals INC. | $18.69 | 2019 | |
| Astellas Pharma US INC | $17.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.83 | 2019 | |
| Amgen INC. | $16.26 | 2019 | |
| 180 Medical, INC. | $16.24 | 2021 | |
| Pfizer INC. | $15.81 | 2019 | |
| Merck Sharp & Dohme LLC | $15.64 | 2019 | |
| Coloplast Corp | $15.35 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $13.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Slavis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.